Your browser doesn't support javascript.
loading
Use of a Genetic Variant Related to Circulating FXa (Activated Factor X) Levels to Proxy the Effect of FXa Inhibition on Cardiovascular Outcomes.
Gill, Dipender; Burgess, Stephen.
Affiliation
  • Gill D; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, United Kingdom (D.G.).
  • Burgess S; Medical Research Council Biostatistics Unit, Cambridge Institute of Public Health (S.B.).
Circ Genom Precis Med ; 13(5): 551-553, 2020 10.
Article in En | MEDLINE | ID: mdl-33079601
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Factor Xa / Factor Xa Inhibitors Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Circ Genom Precis Med Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Factor Xa / Factor Xa Inhibitors Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Circ Genom Precis Med Year: 2020 Document type: Article Country of publication: